The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects
NCT01893515
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
87
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
PRC-4016
DRUG:
Placebo
Sponsor
Pronova BioPharma